Inbjudan till förvärv av aktier i Q-linea AB publ

Forskning vid Uppsala universitet - Uppsala universitet

2015-08-13 Accelerate Diagnostics' stock was trading at $10.61 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, AXDX shares have decreased by 16.4% and is now trading at $8.87. AXDX Stock Trend. The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Accelerate diagnostics stock forecast

Shares in Accelerate Diagnostics Inc are currently priced at $8.69. At that level they are trading at 63.58% discount to the analyst consensus target price of 0.00. Analysts covering Accelerate Diagnostics Inc currently have a consensus Earnings Per Share (EPS) forecast of -1.388 for the next financial year. A high-level overview of Accelerate Diagnostics, Inc. (AXDX) stock.

فرنسا تبدأ استلام لقاح أسترازينيكا الأسبوع المقبل - jobba.nu

If you had invested in Accelerate Diagnostics stock at $27.00, your return over the last 23 years would have been -61.89%, for an annualized return of -4.11%. © Find real-time AEZS - Aeterna Zentaris Inc stock quotes, company profile, news and forecasts from CNN Business. ACCELERATE DIAGNOSTICS, INC. earnings per share revisions and analysts forecast | Nasdaq: AXDX | Nasdaq Accelerate Diagnostics (AXDX) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects.

Omvärldsanalys FoI inom transportområdet 2016

Stock Type Speculative G Accelerate Diagnostics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. AXDX updated stock price target summary. View today's stock price, news and analysis for Accelerate Diagnostics Inc. ( AXDX). Barron's also provides information on historical stock ratings, target prices, View live ACCELERATE DIAGNOSTICS INC chart to track its stock's price action. Find market predictions, AXDX financials and market news. Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it The latest Accelerate Diagnostics Inc USD0.01 share price.

There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Afa 8th annual conference

2021-04-05 · The stock of Accelerate Diagnostics (NAS:AXDX, 30-year Financials) is believed to be possible value trap, according to GuruFocus Value calculation. GuruFocus Value is GuruFocus' estimate of the fair value at which the stock should be traded.

Looking to buy or sell Accelerate Diagnostics, Inc. (AXDX)?
Rautelin

kallforteckning forelasning
studiestress corona
svedsko hrvatski rjecnik
första epa traktorn
rakna ut din manadslon
stjärnsund slottscafe askersund
fa omega

och baer samt: Topics by WorldWideScience.org

(AXDX) Nasdaq Listed. Nasdaq 100. Data is currently not available.

Forstarkt anstallningsstod
dina vingardar

Boule Diagnostics kan bli nästa CellaVision med en rejäl tid

The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe AXDX will outperform the market and that investors should add to their positions of Accelerate Diagnostics. View the latest ratings for AXDX. 2021-02-28 · So things certainly aren't looking great, and you should also know that we've spotted some potential warning signs with Accelerate Diagnostics, including dilutive stock issuance over the past year. 2021-04-09 · Accelerate Diagnostics Inc NASDAQ Updated Apr 9, 2021 8:00 PM. AXDX 8.87 0.19 (2.10%).